Who
Jonathan P. DiVincenzo
President & COO
Company insider
Files Form 4 as: President & COO, Bio-Rad Laboratories; EVP, Pres, Central Labs & Intl, Labcorp Holdings; Please See Remarks, Revvity; Vice President, Millipore Corp /ma.
In numbers
- Trades disclosed
- 64
- Buys
- 0
- Sells
- 1
- Bought
- $0
- Sold
- $108K
- Companies
- 4
- Companies where not an officer
- 0
- First trade
- 11 Feb 2009
- Last trade
- 5 Sep 2026
- Last filed
- 9 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 5 Sep 2026filed 9 Sep 2026 | BIO Bio-Rad LaboratoriesLife-science tools | SEC FORM 4 Code M | —1,712 at $0.00 | filing |
| 5 Sep 2026filed 9 Sep 2026 | BIO Bio-Rad LaboratoriesLife-science tools | SEC FORM 4 Code F | $258K668 at $386.11 | filing |
| 5 Sep 2026filed 9 Sep 2026 | BIO Bio-Rad Laboratoriesoption or derivative · Life-science tools | SEC FORM 4 Code M | —1,712 at $0.00 | filing |
| 5 Sep 2026filed 9 Sep 2026 | BIO Bio-Rad Laboratoriesoption or derivative · Life-science tools | SEC FORM 4 Code M | —1,712 at $0.00 | filing |
| 5 Sep 2026filed 9 Sep 2026 | BIO Bio-Rad LaboratoriesLife-science tools | SEC FORM 4 Code M | —1,712 at $0.00 | filing |
| 5 Sep 2026filed 9 Sep 2026 | BIO Bio-Rad LaboratoriesLife-science tools | SEC FORM 4 Code F | $258K668 at $386.11 | filing |
| 4 Sep 2026filed 9 Sep 2026 | BIO Bio-Rad Laboratoriesoption or derivative · Life-science tools | SEC FORM 4 Code A | —6,326 at $0.00 | filing |
| 4 Sep 2026filed 9 Sep 2026 | BIO Bio-Rad Laboratoriesoption or derivative · Life-science tools | SEC FORM 4 Code A | —6,326 at $0.00 | filing |
| 24 Oct 2025filed 28 Oct 2025 | BIO Bio-Rad Laboratoriesoption or derivative · Life-science tools | SEC FORM 4 Code M | —1,869 at $0.00 | filing |
| 24 Oct 2025filed 28 Oct 2025 | BIO Bio-Rad LaboratoriesLife-science tools | SEC FORM 4 Code M | —1,869 at $0.00 | filing |
| 24 Oct 2025filed 28 Oct 2025 | BIO Bio-Rad LaboratoriesLife-science tools | SEC FORM 4 Code F | $323K950 at $339.75 | filing |
| 5 Sep 2025filed 9 Sep 2025 | BIO Bio-Rad Laboratoriesoption or derivative · Life-science tools | SEC FORM 4 Code A | —6,850 at $0.00 | filing |
| 3 Mar 2025filed 5 Mar 2025 | BIO Bio-Rad Laboratoriesoption or derivative · Life-science tools | SEC FORM 4 Code A | —4,863 at $0.00 | filing |
| 24 Oct 2024filed 25 Oct 2024 | BIO Bio-Rad Laboratoriesoption or derivative · Life-science tools | SEC FORM 4 Code A | —7,478 at $0.00 | filing |
| 27 Mar 2024filed 29 Mar 2024 | LH Labcorp Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —3,012 | filing |
| 27 Mar 2024filed 29 Mar 2024 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Code M | —3,012 | filing |
| 27 Mar 2024filed 29 Mar 2024 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Code F | $206K952 at $216.57 | filing |
| 21 Feb 2024filed 22 Feb 2024 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Sold | $108K500 at $215.49 | filing |
| 12 Feb 2024filed 13 Feb 2024 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Code F | $13K59 at $227.45 | filing |
| 11 Feb 2024filed 13 Feb 2024 | LH Labcorp Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —201 at $0.00 | filing |
News
Labcorp To Buy Myriad Genetics' Prenatal Testing Business For $210 MlnLH · finanzen.ch · 20 Oct 2026Labcorp To Acquire BioReference Health Assets; OPKO Shares Rise 7.35%LH · rttnews.com · 15 Oct 2026Labcorp Enters into Agreement with OPKO Health to Acquire Select Assets of BioReference HealthLH · prnewswire.com · 15 Oct 2026
0 headlines in the last 90 days name Jonathan P. DiVincenzo; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.